Trial intelligence / Profile preview

Phase II dasatinib study in children and adolescents with Philadelphia chromosome-positive leukemia resistant or intolerant to imatinib

RBR-5hzmjxPhase 2Recruiting

Sponsor

Bristol Myers Squibb

Start

Mar 2010

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1